The financing will allow us to accelerate advancement of the company's bacteriophage-containing individual therapeutics for make use of in the treating bacterial infections. Roth Capital Griffin and Companions Securities, Inc. Served as placement agents for the providing. The securities offered in this personal placement transaction possess not been registered beneath the Securities Work of 1933, as amended , or applicable condition securities laws. Accordingly, the securities might not be provided or sold in the United States except pursuant to an effective registration declaration or an applicable exemption from the sign up requirements of the Securities Act and such applicable condition securities laws. Pursuant to the terms of a registration rights contract entered into with the investors, the Company has agreed to file a registration declaration with the Securities and Exchange Commission registering the resale of the shares of common stock sold in the providing.Related StoriesStudy: Safe areas may play critical function in community-based HIV prevention effortsGenvoya approved as full regimen for HIV treatmentDespite reduced HIV/Helps deaths, disease persists in South Africa Â.. Artimplant reports net income of SEK 9.7 million .The net loss totaled SEK 9.0 million . Income per stock device amounted to SEK -0.08 . The result was suffering from one-off products amounting to -0.9 million . Artimplant’s own sales as a proportion of total sales continued to improve and accounted for 72 percent of product sales. The Company has revised its cashflow target and desire to now is a positive cashflow before changes in functioning capital will be performed monthly during the first quarter of 2012 .